Articlenpj metabolic health and disease2026
Liver androgen receptor knockout protects female mice from high fat diet-induced insulin resistance.
Article in npj metabolic health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
High-fat diet (HFD) feeding induces reduced insulin-stimulated AKT phosphorylation with notable sex- and tissue-specific variability, yet the contribution of hepatic androgen receptor (AR) signaling to these effects remains unclear. To investigate the role of hepatic AR in metabolic regulation under dietary stress, liver-specific AR knockout (LivARKO) and wild-type (WT) mice of both sexes were fed control or HFD diets for up to 3 months. HFD impaired insulin-stimulated Akt phosphorylation across liver, skeletal muscle, and white adipose tissue in WT mice. In females, LivARKO preserved hepatic insulin sensitivity and attenuated HFD-induced induction of gluconeogenic genes Pck1 and G6pc, indicating protection from hepatic insulin resistance. This effect was not observed in skeletal muscle or adipose tissue. In contrast, male LivARKO mice showed no protection from HFD-induced insulin resistance and exhibited further upregulation of hepatic Pck1 and G6pc expression compared with WT males. These findings demonstrate a sexually dimorphic role for hepatic AR in regulating insulin signaling and glucose metabolism during HFD feeding. Targeting hepatic AR signaling may offer a sex-specific strategy for mitigating diet-induced metabolic dysfunction and improving metabolic health outcomes.
Identifiers
42823504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.